Selected research
Industry Growth & Trends
Global Genome Sequencing Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Genome Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Genome Sequencing Service market include Illumina, Thermo Fisher Scientific, BGI Genomics, Agilent Technologies, CD Genomics, Azenta Life Sciences, Broad Clinical Labs, Macrogen and GE Healthcare Life Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Genome Sequencing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Genome Sequencing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genome Sequencing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genome Sequencing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Genome Sequencing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Genome Sequencing Service Market by Company
Illumina
Thermo Fisher Scientific
BGI Genomics
Agilent Technologies
CD Genomics
Azenta Life Sciences
Broad Clinical Labs
Macrogen
GE Healthcare Life Sciences
Johnson & Johnson
Abbott Laboratories
Bayer
Microchip Biotechnologies
GeneDx
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Novogene
Eurofins Genomics
Psomagen
Genome Sequencing Service Segment by Type
Whole-Genome Sequencing
Whole exome Sequencing
Others
Genome Sequencing Service Segment by Application
Humanity
Plant
Animal
Microorganism
Virus
Genome Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Genome Sequencing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Whole-Genome Sequencing
- Whole exome Sequencing
- Others
Applications
- Humanity
- Plant
- Animal
- Microorganism
- Virus
Companies covered
- Illumina
- Thermo Fisher Scientific
- BGI Genomics
- Agilent Technologies
- CD Genomics
- Azenta Life Sciences
- Broad Clinical Labs
- Macrogen
- GE Healthcare Life Sciences
- Johnson & Johnson
- Abbott Laboratories
- Bayer
- Microchip Biotechnologies
- GeneDx
- Commonwealth Biotechnologies
- ZS Genetics
- Pacific Biosciences
- Novogene
- Eurofins Genomics
- Psomagen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Genome Sequencing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Genome Sequencing Service Market Size by Region (2021-2032)
- 1.4.1 Global Genome Sequencing Service Market Size by Region (2021-2026)
- 1.4.2 Global Genome Sequencing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Genome Sequencing Service Market Size (2021-2032)
- 1.5.1 North America Genome Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Genome Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Genome Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Genome Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Genome Sequencing Service Market Size Growth Rate (2021-2032)
2 Genome Sequencing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Whole-Genome Sequencing
- 2.1.2 Whole exome Sequencing
- 2.1.3 Others
- 2.2 Global Genome Sequencing Service Market Size by Type
- 2.2.1 Global Genome Sequencing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Genome Sequencing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Genome Sequencing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Genome Sequencing Service Market Size by Regions
- 2.3.1 North America Genome Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Genome Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Genome Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Genome Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Genome Sequencing Service Market Size Breakdown by Type (2021-2026)
3 Genome Sequencing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Humanity
- 3.1.2 Plant
- 3.1.3 Animal
- 3.1.4 Microorganism
- 3.1.5 Virus
- 3.2 Global Genome Sequencing Service Market Size by Application
- 3.2.1 Global Genome Sequencing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Genome Sequencing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Genome Sequencing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Genome Sequencing Service Market Size by Regions
- 3.3.1 North America Genome Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Genome Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Genome Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Genome Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Genome Sequencing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Genome Sequencing Service Industry Trends
- 4.2 Genome Sequencing Service Industry Drivers
- 4.3 Genome Sequencing Service Industry Opportunities and Challenges
- 4.4 Genome Sequencing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Genome Sequencing Service Revenue (2021-2026)
- 5.2 Global Genome Sequencing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Genome Sequencing Service Key Company Headquarters & Area Served
- 5.4 Global Genome Sequencing Service Company, Product Type & Application
- 5.5 Global Genome Sequencing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Genome Sequencing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Genome Sequencing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Genome Sequencing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Illumina
- 6.1.1 Illumina Company Information
- 6.1.2 Illumina Business Overview
- 6.1.3 Illumina Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Illumina Genome Sequencing Service Product Portfolio
- 6.1.5 Illumina Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Thermo Fisher Scientific Genome Sequencing Service Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 BGI Genomics
- 6.3.1 BGI Genomics Company Information
- 6.3.2 BGI Genomics Business Overview
- 6.3.3 BGI Genomics Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BGI Genomics Genome Sequencing Service Product Portfolio
- 6.3.5 BGI Genomics Recent Developments
- 6.4 Agilent Technologies
- 6.4.1 Agilent Technologies Company Information
- 6.4.2 Agilent Technologies Business Overview
- 6.4.3 Agilent Technologies Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Agilent Technologies Genome Sequencing Service Product Portfolio
- 6.4.5 Agilent Technologies Recent Developments
- 6.5 CD Genomics
- 6.5.1 CD Genomics Company Information
- 6.5.2 CD Genomics Business Overview
- 6.5.3 CD Genomics Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 CD Genomics Genome Sequencing Service Product Portfolio
- 6.5.5 CD Genomics Recent Developments
- 6.6 Azenta Life Sciences
- 6.6.1 Azenta Life Sciences Company Information
- 6.6.2 Azenta Life Sciences Business Overview
- 6.6.3 Azenta Life Sciences Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Azenta Life Sciences Genome Sequencing Service Product Portfolio
- 6.6.5 Azenta Life Sciences Recent Developments
- 6.7 Broad Clinical Labs
- 6.7.1 Broad Clinical Labs Company Information
- 6.7.2 Broad Clinical Labs Business Overview
- 6.7.3 Broad Clinical Labs Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Broad Clinical Labs Genome Sequencing Service Product Portfolio
- 6.7.5 Broad Clinical Labs Recent Developments
- 6.8 Macrogen
- 6.8.1 Macrogen Company Information
- 6.8.2 Macrogen Business Overview
- 6.8.3 Macrogen Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Macrogen Genome Sequencing Service Product Portfolio
- 6.8.5 Macrogen Recent Developments
- 6.9 GE Healthcare Life Sciences
- 6.9.1 GE Healthcare Life Sciences Company Information
- 6.9.2 GE Healthcare Life Sciences Business Overview
- 6.9.3 GE Healthcare Life Sciences Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GE Healthcare Life Sciences Genome Sequencing Service Product Portfolio
- 6.9.5 GE Healthcare Life Sciences Recent Developments
- 6.10 Johnson & Johnson
- 6.10.1 Johnson & Johnson Company Information
- 6.10.2 Johnson & Johnson Business Overview
- 6.10.3 Johnson & Johnson Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Johnson & Johnson Genome Sequencing Service Product Portfolio
- 6.10.5 Johnson & Johnson Recent Developments
- 6.11 Abbott Laboratories
- 6.11.1 Abbott Laboratories Company Information
- 6.11.2 Abbott Laboratories Business Overview
- 6.11.3 Abbott Laboratories Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Abbott Laboratories Genome Sequencing Service Product Portfolio
- 6.11.5 Abbott Laboratories Recent Developments
- 6.12 Bayer
- 6.12.1 Bayer Company Information
- 6.12.2 Bayer Business Overview
- 6.12.3 Bayer Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Bayer Genome Sequencing Service Product Portfolio
- 6.12.5 Bayer Recent Developments
- 6.13 Microchip Biotechnologies
- 6.13.1 Microchip Biotechnologies Company Information
- 6.13.2 Microchip Biotechnologies Business Overview
- 6.13.3 Microchip Biotechnologies Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Microchip Biotechnologies Genome Sequencing Service Product Portfolio
- 6.13.5 Microchip Biotechnologies Recent Developments
- 6.14 GeneDx
- 6.14.1 GeneDx Company Information
- 6.14.2 GeneDx Business Overview
- 6.14.3 GeneDx Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 GeneDx Genome Sequencing Service Product Portfolio
- 6.14.5 GeneDx Recent Developments
- 6.15 Commonwealth Biotechnologies
- 6.15.1 Commonwealth Biotechnologies Company Information
- 6.15.2 Commonwealth Biotechnologies Business Overview
- 6.15.3 Commonwealth Biotechnologies Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Commonwealth Biotechnologies Genome Sequencing Service Product Portfolio
- 6.15.5 Commonwealth Biotechnologies Recent Developments
- 6.16 ZS Genetics
- 6.16.1 ZS Genetics Company Information
- 6.16.2 ZS Genetics Business Overview
- 6.16.3 ZS Genetics Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 ZS Genetics Genome Sequencing Service Product Portfolio
- 6.16.5 ZS Genetics Recent Developments
- 6.17 Pacific Biosciences
- 6.17.1 Pacific Biosciences Company Information
- 6.17.2 Pacific Biosciences Business Overview
- 6.17.3 Pacific Biosciences Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Pacific Biosciences Genome Sequencing Service Product Portfolio
- 6.17.5 Pacific Biosciences Recent Developments
- 6.18 Novogene
- 6.18.1 Novogene Company Information
- 6.18.2 Novogene Business Overview
- 6.18.3 Novogene Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Novogene Genome Sequencing Service Product Portfolio
- 6.18.5 Novogene Recent Developments
- 6.19 Eurofins Genomics
- 6.19.1 Eurofins Genomics Company Information
- 6.19.2 Eurofins Genomics Business Overview
- 6.19.3 Eurofins Genomics Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Eurofins Genomics Genome Sequencing Service Product Portfolio
- 6.19.5 Eurofins Genomics Recent Developments
- 6.20 Psomagen
- 6.20.1 Psomagen Company Information
- 6.20.2 Psomagen Business Overview
- 6.20.3 Psomagen Genome Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Psomagen Genome Sequencing Service Product Portfolio
- 6.20.5 Psomagen Recent Developments
7 North America
- 7.1 North America Genome Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Genome Sequencing Service Market Size by Country (2021-2026)
- 7.3 North America Genome Sequencing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Genome Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Genome Sequencing Service Market Size by Country (2021-2026)
- 8.3 Europe Genome Sequencing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Genome Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Genome Sequencing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Genome Sequencing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Genome Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Genome Sequencing Service Market Size by Country (2021-2026)
- 10.3 South America Genome Sequencing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Genome Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Genome Sequencing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Genome Sequencing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst